The price of this share is at 4,29$, G1 Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Jennifer K. Moses (Chief Financial Officer), Mark Avagliano (Chief Business Officer), Rajesh K. Malik (Chief Medical Officer), Terry L. Murdock (Chief Operating Officer) and its address is 700 PARK OFFICES DRIVE SUITE 200, RESEARCH TRIANGLE PARK, North Carolina, 27709, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 4,44$ moving between 4,27$ and 4,60$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
